USANA Health Sciences, Inc. (NYSE:USNA) Position Decreased by Cypress Capital LLC

Cypress Capital LLC decreased its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 9.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,262 shares of the company’s stock after selling 834 shares during the period. Cypress Capital LLC’s holdings in USANA Health Sciences were worth $297,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in USNA. Pacer Advisors Inc. boosted its position in shares of USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock valued at $20,638,000 after purchasing an additional 76,904 shares in the last quarter. Pzena Investment Management LLC boosted its position in shares of USANA Health Sciences by 7.5% during the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock valued at $39,801,000 after purchasing an additional 72,977 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after purchasing an additional 38,547 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in shares of USANA Health Sciences by 13.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after purchasing an additional 14,756 shares in the last quarter. Finally, Barclays PLC boosted its position in shares of USANA Health Sciences by 111.9% during the 3rd quarter. Barclays PLC now owns 27,737 shares of the company’s stock valued at $1,052,000 after purchasing an additional 14,647 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Trading Down 0.8 %

USNA stock opened at $31.85 on Friday. USANA Health Sciences, Inc. has a one year low of $30.13 and a one year high of $50.32. The firm has a market capitalization of $607.02 million, a PE ratio of 11.25, a P/E/G ratio of 0.93 and a beta of 0.87. The firm has a 50-day moving average of $33.81 and a two-hundred day moving average of $36.77.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on USNA. DA Davidson raised their price objective on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research report on Thursday, January 2nd. Sidoti lowered shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Finally, StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.